Generalized cognitive deficits in schizophrenia: a study of first-episode patients - PubMed (original) (raw)
Generalized cognitive deficits in schizophrenia: a study of first-episode patients
S Mohamed et al. Arch Gen Psychiatry. 1999 Aug.
Abstract
Background: Cognitive impairment is recognized as a core characteristic of schizophrenia. There has always been a debate about the nature, selectivity, and time of onset of these deficits in relationship to the onset of illness and treatment factors. To our knowledge, the present study represents the largest sample of mostly neuroleptic-naive patients with first-episode schizophrenia that has been reported to date.
Methods: A group of 94 patients experiencing their first episode of schizophrenic illness and 305 normal comparison subjects were administered a comprehensive clinical and neuropsychological evaluation. Seventy-three patients were neuroleptic naive, 14 had received treatment for less than 1 week, and the remaining 7 had been medicated for less than 2 weeks.
Results: Patients performed significantly worse than the comparison subjects on every neuropsychological variable except those assessing savings scores (ie, forgetting over time). Twenty-five of 30 tests had an effect size (ES) greater than 0.75 when the 2 groups were compared. An ES analysis within the schizophrenia group revealed that the greatest relative impairments were on the Wechsler Adult Intelligence Scale-Revised digit symbol (ES, -0.52) and comprehension (ES, -0.42) subscales.
Conclusions: Our findings are in concert with others demonstrating that significant cognitive impairment across multiple ability domains is a core characteristic of schizophrenia and is not caused by chronic illness, treatment, or institutionalization. The ES analysis emphasizes that patients with schizophrenia have a generalized deficit that is not easily explained by a single anatomical region or ability area.
Similar articles
- [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Bralet MC, et al. Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French. - Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA. Bilder RM, et al. Am J Psychiatry. 2000 Apr;157(4):549-59. doi: 10.1176/appi.ajp.157.4.549. Am J Psychiatry. 2000. PMID: 10739413 - Distinct contribution of working memory and social comprehension failures in neuropsychological impairment in schizophrenia.
Nestor PG, Niznikiewicz M, McCarley RW. Nestor PG, et al. J Nerv Ment Dis. 2010 Mar;198(3):206-12. doi: 10.1097/NMD.0b013e3181d14143. J Nerv Ment Dis. 2010. PMID: 20215998 - [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L, Meunier-Cussac S, Dollfus S. Lecardeur L, et al. Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Encephale. 2013. PMID: 23528322 Review. French. - [First-episode psychosis, cognitive difficulties and remediation].
Vidailhet P. Vidailhet P. Encephale. 2013 Sep;39 Suppl 2:S83-92. doi: 10.1016/S0013-7006(13)70101-5. Encephale. 2013. PMID: 24084427 Review. French.
Cited by
- Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial.
Leweke FM, Rohleder C, Gerth CW, Hellmich M, Pukrop R, Koethe D. Leweke FM, et al. Front Pharmacol. 2021 Apr 29;12:614811. doi: 10.3389/fphar.2021.614811. eCollection 2021. Front Pharmacol. 2021. PMID: 33995015 Free PMC article. - Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.
Cirillo MA, Seidman LJ. Cirillo MA, et al. Neuropsychol Rev. 2003 Jun;13(2):43-77. doi: 10.1023/a:1023870821631. Neuropsychol Rev. 2003. PMID: 12887039 Review. - Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training.
Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, Carter CS, Vinogradov S. Ramsay IS, et al. Schizophr Res Cogn. 2017 Nov 8;11:1-5. doi: 10.1016/j.scog.2017.10.001. eCollection 2018 Mar. Schizophr Res Cogn. 2017. PMID: 29159134 Free PMC article. - Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume.
Ohi K, Shimada T, Nemoto K, Kataoka Y, Yasuyama T, Kimura K, Okubo H, Uehara T, Kawasaki Y. Ohi K, et al. Neuroimage Clin. 2017 Aug 8;16:248-256. doi: 10.1016/j.nicl.2017.08.008. eCollection 2017. Neuroimage Clin. 2017. PMID: 28831376 Free PMC article. - Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
Correll CU, Smith CW, Auther AM, McLaughlin D, Shah M, Foley C, Olsen R, Lencz T, Kane JM, Cornblatt BA. Correll CU, et al. J Child Adolesc Psychopharmacol. 2008 Oct;18(5):475-90. doi: 10.1089/cap.2007.110. J Child Adolesc Psychopharmacol. 2008. PMID: 18928412 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical